Sign in
Join
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
My Account
orders
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Home
Tags
JNCE
Tag: JNCE
Analyst Downgrades – NASDAQ:JNCE – Jounce Therapeutics (NASDAQ:JNCE) Stock Gets Downgraded...
ME Staff
-
June 5, 2018
0
Analyst Downgrades – NASDAQ:JNCE – Jounce Therapeutics (NASDAQ:JNCE) Stock Gets Downgraded...
ME Staff
-
June 5, 2018
0
ME Staff
-
June 4, 2018
0
Analyst Activity – Robert W. Baird Reiterates Buy on NASDAQ:JNCE –...
ME Staff
-
June 4, 2018
0
Analyst Downgrades – NASDAQ:JNCE – Jounce Therapeutics (NASDAQ:JNCE) Stock Gets Downgraded...
ME Staff
-
May 17, 2018
0
Analyst Downgrades – NASDAQ:JNCE – Jounce Therapeutics (NASDAQ:JNCE) Stock Gets Downgraded...
ME Staff
-
May 17, 2018
0
Analyst Activity – HC Wainwright Initiates Coverage On NASDAQ:JNCE – Jounce...
ME Staff
-
April 27, 2018
0
Jounce Therapeutics (NASDAQ:JNCE) reported earnings of ($0.29) per share beating Walls...
ME Staff
-
March 8, 2018
0
Jounce Therapeutics, Inc. (NASDAQ:JNCE) reported earnings of ($0.11) per share beating...
ME Staff
-
August 9, 2017
0
JOUNCE THERAPEUTICS, INC. (NASDAQ:JNCE) Files An 8-K Termination of a Material...
ME Staff 8-k
-
May 23, 2017
0
1
2
Page 1 of 2
/* */
// AST – IMS - [MarketExclusive_ROS]
